Commercial, Energy Efficiency, GHG Emissions  -  February 8, 2024

Cencora’s Goals Approved by SBTi

Cencora (formerly AmerisourceBergen), a global healthcare company, announced its near-term science-based emissions target has been set and validated by the Science Based Targets initiative (SBTi).

The company’s plan is to lower Scope 1 and 2 GHG emissions by 54.6% by FY2032. Cencora has already lowered its emissions by nearly 2% from its base year and investments in renewable energy globally are also being conducted.

Cencora has also incorporated sustainable packaging solutions, which resulted in more than 40% of World Courier shipments utilizing reusable packaging. 

The company has been included in the S&P Global Sustainability Yearbook 2024. Members are selected based on their score from the S&P Global 2023 Corporate Sustainability Assessment (CSA). To be listed in the Yearbook, companies must score within the top 15% of their industry and achieve a CSA Score within 30% of their industry’s top-performing company.

Details were released in Cencora's 2023 Environmental, Social and Governance (ESG) Report. 

“Cencora’s approach to ESG is a direct reflection of our purpose and responsibility to create healthier futures,” said Gina Clark, EVP and Chief Communications & Administration Officer at Cencora, in a statement. “Our critical role at the center of the global pharmaceutical value chain enables us to advance our key priorities supporting purpose-driven team members, resilient and sustainable operations, and healthy customers and communities. I’m proud of the impact we’ve had over the past year, but our work to achieve our ESG priorities, inclusive of our work in diversity, equity and inclusion, continues. Through partnership, innovation, and most importantly – purpose – these efforts will continue to be at the core of everything that we do.”